JP2004534016A - 抗菌剤 - Google Patents

抗菌剤 Download PDF

Info

Publication number
JP2004534016A
JP2004534016A JP2002584900A JP2002584900A JP2004534016A JP 2004534016 A JP2004534016 A JP 2004534016A JP 2002584900 A JP2002584900 A JP 2002584900A JP 2002584900 A JP2002584900 A JP 2002584900A JP 2004534016 A JP2004534016 A JP 2004534016A
Authority
JP
Japan
Prior art keywords
amino acids
domain
substance
use according
bacterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002584900A
Other languages
English (en)
Japanese (ja)
Inventor
マイヤー フランク
Original Assignee
ノヴォロギックス ゲゼルシャフト ミット ベシュレンクテル ハフツング
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10129870A external-priority patent/DE10129870A1/de
Application filed by ノヴォロギックス ゲゼルシャフト ミット ベシュレンクテル ハフツング filed Critical ノヴォロギックス ゲゼルシャフト ミット ベシュレンクテル ハフツング
Publication of JP2004534016A publication Critical patent/JP2004534016A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2002584900A 2001-04-30 2002-04-22 抗菌剤 Pending JP2004534016A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10121145 2001-04-30
DE10129870A DE10129870A1 (de) 2001-04-30 2001-06-21 Antibakterielles Mittel
PCT/EP2002/004410 WO2002087554A2 (de) 2001-04-30 2002-04-22 Ef-tu-bindende substanzen als ntibakterielles mittel

Publications (1)

Publication Number Publication Date
JP2004534016A true JP2004534016A (ja) 2004-11-11

Family

ID=26009202

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002584900A Pending JP2004534016A (ja) 2001-04-30 2002-04-22 抗菌剤

Country Status (17)

Country Link
EP (1) EP1397157A2 (zh)
JP (1) JP2004534016A (zh)
CN (1) CN1298739C (zh)
AU (1) AU2002302555B2 (zh)
BG (1) BG108399A (zh)
BR (1) BR0209282A (zh)
CA (1) CA2445995A1 (zh)
CZ (1) CZ20033271A3 (zh)
EE (1) EE200300530A (zh)
HU (1) HUP0401586A3 (zh)
IL (1) IL158627A0 (zh)
MX (1) MXPA03009954A (zh)
NZ (1) NZ529662A (zh)
PL (1) PL366836A1 (zh)
RU (1) RU2003134636A (zh)
SK (1) SK14792003A3 (zh)
WO (1) WO2002087554A2 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10229645A1 (de) * 2002-07-02 2004-05-19 Kuchenreuther, Ulrich, Dr. Zellaufschluss von Bakterien
PT2459176T (pt) 2009-07-31 2017-12-11 Gruenenthal Gmbh Método de cristalização e biodisponibilidade
US9169279B2 (en) 2009-07-31 2015-10-27 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
US20160016982A1 (en) 2009-07-31 2016-01-21 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
WO2012071517A2 (en) 2010-11-24 2012-05-31 Thar Pharmaceuticals, Inc. Novel crystalline forms
CN105218668B (zh) * 2015-10-30 2020-03-24 山东农业大学 马耳他型布氏杆菌的EF-Tu蛋白单克隆抗体MAb及其制备方法与应用
US10195218B2 (en) 2016-05-31 2019-02-05 Grunenthal Gmbh Crystallization method and bioavailability

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0466251A1 (en) * 1990-07-10 1992-01-15 Gist-Brocades N.V. Elfamycin-resistant mutants
ES2275336T3 (es) * 1998-01-23 2007-06-01 Biomerieux B.V. Arnm del ef-tu para determinar la viabilidad de bacterias.
US6451556B1 (en) * 1998-12-21 2002-09-17 Smithkline Beecham Corporation EF-Tu

Also Published As

Publication number Publication date
AU2002302555B2 (en) 2007-08-23
CZ20033271A3 (en) 2004-06-16
WO2002087554B1 (de) 2005-01-27
BG108399A (bg) 2004-08-31
HUP0401586A2 (hu) 2004-11-29
WO2002087554A2 (de) 2002-11-07
CN1298739C (zh) 2007-02-07
EP1397157A2 (de) 2004-03-17
CN1518455A (zh) 2004-08-04
HUP0401586A3 (en) 2005-06-28
WO2002087554A3 (de) 2003-01-30
PL366836A1 (en) 2005-02-07
EE200300530A (et) 2004-04-15
IL158627A0 (en) 2004-05-12
BR0209282A (pt) 2004-07-27
MXPA03009954A (es) 2005-07-25
SK14792003A3 (sk) 2004-07-07
NZ529662A (en) 2006-08-31
RU2003134636A (ru) 2005-04-20
CA2445995A1 (en) 2002-11-07

Similar Documents

Publication Publication Date Title
FI120236B (fi) Kopolymeeri-1 parannuksia kopolymeerien seoksiin
Secker et al. Poly (α‐Peptoid) s Revisited: Synthesis, Properties, and Use as Biomaterial
Stockmann et al. Multimeric vitronectin. Identification and characterization of conformation-dependent self-association of the adhesive protein.
US20070003554A1 (en) Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha
Leo et al. First analysis of a bacterial collagen-binding protein with collagen Toolkits: promiscuous binding of YadA to collagens may explain how YadA interferes with host processes
ES2290023T3 (es) Moduladores de la agregacion del peptido beta-amiloide que comprenden d-aminoacidos.
JP2004534016A (ja) 抗菌剤
Zhang et al. RV-23, a melittin-related peptide with cell-selective antibacterial activity and high hemocompatibility
EP3655421B1 (en) Methods for purifying proteins having a tubulin carboxypeptidase activity and peptidic based inhibitors thereof
US8071640B2 (en) Urea oligomers, their preparation process and pharmaceutical compositions containing them
Krishnakumari et al. Escherichia coli Lipopolysaccharide modulates biological activities of human-β-defensin analogues but not non-ribosomally synthesized peptides
US20100286027A1 (en) Anti-bacterial compositions
RU2620070C2 (ru) Модифицированные пептиды и их применение для лечения аутоиммунных заболеваний
US20050192221A1 (en) Methods and compositions related to plunc polypeptides
US20090048176A1 (en) Antibacterial agent
US7659366B2 (en) Peptide with putative role in cytoskeletal protection
EP3356384B1 (en) Polypeptides comprising vinculin binding sites for the treatment of proliferation and/or adhesion related diseases
EP4417617A1 (en) Mitochondria-specific peptide that can be intracellularly delivered at nanomolar concentration, and use thereof
Zhang et al. Intermolecular Interactions and Self-Assembly of Peptide-Based Nanomaterials Against Human Pathogenic Bacteria
Lie et al. Synthesis and biological activity of four kinds of reversed peptides
Zobiak Fibronectin binding protein A-mediated cellular infections by Staphylococcus aureus (Rosenbach, 1884)
Zobiak Fibronectin binding protein A-mediated cellular infections by Staphylococcus aureus
WO2004032955A1 (ja) カルシニューリンの恒常的活性化阻害剤
EP1691197A2 (en) Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha
Seischab Interactions of actin with human neutrophil elastase and secretory leukocyte protease inhibitor

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050408

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080626

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20080825

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20080901

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081226

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090402